07/07/2026 21:47
|
Biotechnology
Novo Nordisk will conduct a non-exclusive internal evaluation of semaglutide implants prepared by Vivani
ALAMEDA, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (Nasdaq: VANI)...